(Q34266793)

1 August 2017

1 reference

title

The role of probiotics in the treatment and prevention of Helicobacter pylori infection (English)

1 reference

Helicobacter pylori infectious disease

1 August 2017

0 references

0 references

1 reference

1 reference

Hamilton-Miller JM

1

1 reference

1 August 2017

J. M T. Hamilton-Miller

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14522098

17 March 2024

language of work or name

1 reference

1 October 2003

1 reference

full work available at URL

1 August 2017

https://api.elsevier.com/content/article/PII:S0924857903001535?httpAccept=text/xml

1 reference

10.1016/S0924-8579(03)00153-5

DOI

https://api.crossref.org/works/10.1016/S0924-8579(03)00153-5

https://api.elsevier.com/content/article/PII:S0924857903001535?httpAccept=text/plain

17 March 2024

1 reference

10.1016/S0924-8579(03)00153-5

DOI

https://api.crossref.org/works/10.1016/S0924-8579(03)00153-5

International Journal of Antimicrobial Agents

17 March 2024

published in

1 reference

1 August 2017

22

1 reference

1 August 2017

360-366

1 reference

1 August 2017

4

1 reference

Probiotics: an overview of beneficial effects.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Probiotics and non-intestinal infectious conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Antimicrobial substance from a human Lactobacillus strain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Lactobacillus acidophilus administration added to omeprazole/amoxycillin-based double therapy in Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Probiotics in clinical conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Antibiotic properties of bovine lactoferrin on Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Human milk kappa-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BAlb/cA mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

Does bovine lactoferrin inhibit Helicobacter pylori?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900153-5

7 January 2021

10.1016/S0924-8579(03)00153-5

Identifiers

DOI

1 reference

1 August 2017

1 reference